News & Events

August 11, 2011

Avantra Biosciences

Avantra Biosciences teams with TGen Drug Development to assist pharma.

August 25, 2011

TGen Drug Development (TD2) partnership with Imaging Endpoints provides comprehensive clinical trial services for drug developers

TGen Drug Development (TD2) and Imaging Endpoints have teamed up to enable the rapid development of anti-cancer...

CytRx Initiates Phase 2 Clinical Trial with INNO-206 in Pancreatic Cancer

Daniel Von Hoff, M.D., Physician-in-Chief and Distinguished Professor at the Translational Genomics Research...

Flagship Biosciences finds Arizona a great home for serving pathology digitally

While most of Flagship’s customers are at biotech and pharma locations around the world, there has been...

News

PM360: COVID-19’s Long-Lasting Impact on Clinical Trials

RCT Acquires Translational Drug Development, LLC

TD2 Business Continuity during COVID-19

January 16, 2020

BioSpace: What Does 2020 Have in Store for Life Sciences?

Genzada Pharmaceuticals Doses First Patient

Events

Virtual J. P. Morgan Speaking Engagement: Data Driven and A.I. Enabled Clinical Solutions to Enhance Cancer Patient Outcomes

Date:January 11, 2021

Location:

Time:2:00 pm

AACR Virtual Meeting

Date:April 27, 2020

Location:GoTo Meeting

Time:5:30 pm

Stay in Touch

Get free tips, tools and resources by subscribing to the TD2 newsletter.

©2021 Translational Drug Development. All Rights Reserved.
Terms and Conditions | Privacy Policy | Sitemap